» Articles » PMID: 39843492

Saponin-based Adjuvant Uptake and Induction of Antigen Cross-presentation by CD11b+ Dendritic Cells and Macrophages

Overview
Journal NPJ Vaccines
Date 2025 Jan 22
PMID 39843492
Authors
Affiliations
Soon will be listed here.
Abstract

Saponin-based adjuvants (SBAs) distinguish themselves as vaccine adjuvants by instigating a potent activation of CD8+ T cells. Previously, we discovered SBA's ability to induce cross-presentation in dendritic cells (DCs) leading to CD8+ T cell activation. Moreover, the MHCIICD11b bone marrow-derived DC (BMDC) subset was identified to be the most responsive DC subset to SBA treatment. To further investigate SBA's mode of action, labeling of SBAs was optimized with the fluorescent dye SP-DiIC(3). Efficient uptake of SBAs occurs specifically by MHCIICD11b BMDCs and bone marrow-derived macrophages (BMDMs) in vitro and cDC2s and macrophages ex vivo. Furthermore, SBAs are primarily taken up by clathrin-mediated endocytosis and uptake induces lipid bodies and antigen translocation to the cytosol in MHCIICD11b BMDCs and BMDMs. Importantly, BMDMs treated with SBAs exhibit cross-presentation leading to potent CD8+ T cells activation. Our findings explain the potency of SBAs as vaccine adjuvants and contribute to vaccine development.

References
1.
Dingjan I, Verboogen D, Paardekooper L, Revelo N, Sittig S, Visser L . Lipid peroxidation causes endosomal antigen release for cross-presentation. Sci Rep. 2016; 6:22064. PMC: 4764948. DOI: 10.1038/srep22064. View

2.
Magnusson S, Reimer J, Karlsson K, Lilja L, Lovgren Bengtsson K, Stertman L . Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice. Vaccine. 2013; 31(13):1725-33. DOI: 10.1016/j.vaccine.2013.01.039. View

3.
Olzmann J, Carvalho P . Dynamics and functions of lipid droplets. Nat Rev Mol Cell Biol. 2018; 20(3):137-155. PMC: 6746329. DOI: 10.1038/s41580-018-0085-z. View

4.
Lutz M, Inaba K, Schuler G, Romani N . Still Alive and Kicking: In-Vitro-Generated GM-CSF Dendritic Cells!. Immunity. 2016; 44(1):1-2. DOI: 10.1016/j.immuni.2015.12.013. View

5.
Heath P, Galiza E, Baxter D, Boffito M, Browne D, Burns F . Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine. N Engl J Med. 2021; 385(13):1172-1183. PMC: 8262625. DOI: 10.1056/NEJMoa2107659. View